222 related articles for article (PubMed ID: 17954056)
21. Clinical relevance of endothelin B-mediated vasoconstriction in lambs with increased pulmonary blood flow.
Langleben D
Circulation; 2004 Apr; 109(14):e183; author reply e183. PubMed ID: 15078812
[No Abstract] [Full Text] [Related]
22. Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation.
Wenzel RR; Siffert W; Bruck H; Philipp T; Schäfers RF
Pharmacogenetics; 2002 Aug; 12(6):489-95. PubMed ID: 12172218
[TBL] [Abstract][Full Text] [Related]
23. Analysis of ET-A and ET-B receptors using an isolated perfused rat lung preparation.
Granström B; Nilsson E; Hultkvist-Bengtsson U; Edvinsson L
Acta Physiol Scand; 2004 Jun; 181(2):259-64. PubMed ID: 15180799
[TBL] [Abstract][Full Text] [Related]
24. Effects of antagonists for endothelin ET(A) and ET(B) receptors on coronary endothelial and myocardial function after ischemia-reperfusion in anesthetized goats.
Climent B; Fernández N; García-Villalón AL; Monge L; Sánchez A; Diéguez G
Vascul Pharmacol; 2006 May; 44(5):384-90. PubMed ID: 16580265
[TBL] [Abstract][Full Text] [Related]
25. ET-1-induced pulmonary vasoconstriction shifts from ET(A)- to ET(B)-receptor-mediated reaction after preconstriction.
Schmeck J; Gluth H; Mihaljevic N; Born M; Wendel-Wellner M; Krafft P
J Appl Physiol (1985); 1999 Dec; 87(6):2284-9. PubMed ID: 10601179
[TBL] [Abstract][Full Text] [Related]
26. Comparison of nitroprusside and nitroglycerin in inhibition of angiotensin II and other vasoconstrictor-mediated contraction in human coronary bypass conduits.
He GW; Yang CQ
Br J Clin Pharmacol; 1997 Oct; 44(4):361-7. PubMed ID: 9354311
[TBL] [Abstract][Full Text] [Related]
27. Endothelin-1 potentiation of coronary artery contraction after ischemia-reperfusion.
García-Villalón AL; Amezquita YM; Monge L; Fernández N; Salcedo A; Diéguez G
Vascul Pharmacol; 2008; 48(2-3):109-14. PubMed ID: 18262852
[TBL] [Abstract][Full Text] [Related]
28. Exaggerated coronary vasoreactivity to endothelin-1 in aged rats: role of protein kinase C.
Korzick DH; Muller-Delp JM; Dougherty P; Heaps CL; Bowles DK; Krick KK
Cardiovasc Res; 2005 May; 66(2):384-92. PubMed ID: 15820207
[TBL] [Abstract][Full Text] [Related]
29. Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats.
Chan CC; Wang SS; Lee FY; Chang FY; Lin HC; Hou MC; Huang HC; Lee SD
Eur J Clin Invest; 2004 Apr; 34(4):290-6. PubMed ID: 15086361
[TBL] [Abstract][Full Text] [Related]
30. Endothelin receptors in endothelium-denuded human coronary artery bypass grafts and coronary arteries.
Wackenfors A; Ingemansson R; Malmsjö M
Ann Thorac Surg; 2003 Mar; 75(3):874-81. PubMed ID: 12645710
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological characteristics of endothelin receptors on sheep rectal blood vessels.
Lohsiriwat V; Scholefield JH; Dashwood MR; Wilson VG
Pharmacol Res; 2011 Jun; 63(6):490-5. PubMed ID: 21382493
[TBL] [Abstract][Full Text] [Related]
32. Vasorelaxation induced by new third-generation dihydropyridine calcium antagonist azelnidipine in human internal mammary artery.
Gao G; Liu XC; Jing WB; Yang Q; He GW
Ann Thorac Surg; 2013 Oct; 96(4):1316-1321. PubMed ID: 23895889
[TBL] [Abstract][Full Text] [Related]
33. Increased vascular angiotensin II binding capacity and ET-1 release in young cardiomyopathic hamsters.
Crespo MJ; Altieri PI; Escobales N
Vascul Pharmacol; 2006 Apr; 44(4):247-52. PubMed ID: 16503205
[TBL] [Abstract][Full Text] [Related]
34. Role of endothelin ET(A) and ET(B) receptor subtypes in the regulation of intrarenal blood flow and oxygen tension in rats.
Nitescu N; Grimberg E; Herlitz H; Guron G
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1227-32. PubMed ID: 18518881
[TBL] [Abstract][Full Text] [Related]
35. Effects of calcium- and ETA-receptor antagonists on endothelin-induced vasoconstriction and levels of endothelin in the human internal mammary artery.
Liu JJ; Casley D; Wojta J; Gallicchio M; Dauer R; Johnston CI; Buxton BF
Clin Exp Pharmacol Physiol; 1994 Jan; 21(1):49-57. PubMed ID: 8156652
[TBL] [Abstract][Full Text] [Related]
36. Nonpeptide endothelin receptor antagonists. IX. Characterization of endothelin receptors in guinea pig bronchus with SB 209670 and other endothelin receptor antagonists.
Hay DW; Luttmann MA
J Pharmacol Exp Ther; 1997 Feb; 280(2):959-65. PubMed ID: 9023312
[TBL] [Abstract][Full Text] [Related]
37. Contribution of endothelin 1 to the vascular effects of diesel exhaust inhalation in humans.
Langrish JP; Lundbäck M; Mills NL; Johnston NR; Webb DJ; Sandström T; Blomberg A; Newby DE
Hypertension; 2009 Oct; 54(4):910-5. PubMed ID: 19687345
[TBL] [Abstract][Full Text] [Related]
38. Endothelin-mediated vasoconstriction in postischemic newborn intestine.
Nankervis CA; Schauer GM; Miller CE
Am J Physiol Gastrointest Liver Physiol; 2000 Oct; 279(4):G683-91. PubMed ID: 11005754
[TBL] [Abstract][Full Text] [Related]
39. Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro.
Maguire JJ; Kuc RE; Davenport AP
Br J Pharmacol; 2001 Nov; 134(6):1360-6. PubMed ID: 11704658
[TBL] [Abstract][Full Text] [Related]
40. Basal inhibitory action of endogenous endothelin on the sympathetic contraction in the isolated rat tail artery.
García-Villalón AL; Monge L; Fernández N; Sánchez MA; Martínez MA; Gómez B; Diéguez G
Eur J Pharmacol; 1999 Nov; 384(2-3):163-7. PubMed ID: 10611437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
